Sarilumab plus methotrexate suppresses circulating biomarkers of bone resorption and synovial damage in patients with rheumatoid arthritis and inadequate response to methotrexate: a biomarker study of MOBILITY
Crossref DOI link: https://doi.org/10.1186/s13075-016-1132-9
Published Online: 2016-10-06
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Boyapati, Anita
Msihid, Jérôme
Fiore, Stefano
van Adelsberg, Janet
Graham, Neil M. H.
Hamilton, Jennifer D.
Funding for this research was provided by:
Sanofi
Regeneron Pharmaceuticals, Inc
